- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7125 - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
Patent holdings for IPC class A61K 31/7125
Total number of patents in this class: 1599
10-year publication summary
|
72
|
87
|
96
|
141
|
144
|
162
|
175
|
156
|
206
|
52
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ionis Pharmaceuticals, Inc. | 776 |
117 |
| Alnylam Pharmaceuticals, Inc. | 1066 |
42 |
| Sarepta Therapeutics, Inc. | 353 |
35 |
| ProQR Therapeutics II B.V. | 102 |
29 |
| Wave Life Sciences Ltd. | 151 |
26 |
| Geron Corporation | 169 |
25 |
| The Board of Regents of the University of Texas System | 2043 |
25 |
| Hoffmann-La Roche Inc. | 3060 |
23 |
| Nippon Shinyaku Co., Ltd. | 297 |
22 |
| Antisense Therapeutics Ltd. | 31 |
18 |
| F. Hoffmann-La Roche AG | 7958 |
17 |
| Regulus Therapeutics Inc. | 70 |
16 |
| Roche Innovation Center Copenhagen A/S | 148 |
16 |
| Bio-Path Holdings, Inc. | 25 |
15 |
| Biogen MA Inc. | 926 |
15 |
| Daiichi Sankyo Company, Limited | 1829 |
15 |
| University of Massachusetts | 2130 |
15 |
| Secarna Pharmaceuticals GmbH & Co KG | 39 |
15 |
| The Regents of the University of California | 18943 |
14 |
| Arrowhead Pharmaceuticals, Inc. | 216 |
14 |
| Other owners | 1085 |